STERIALS

A biopharmaceutical company focused on developing and commercializing treatments for cancer, autoimmune diseases, infectious diseases, and neurological diseases. In partnership with major global biopharmaceutical companies, the company has commercialized treatments for epithelial ovarian cancer maintenance therapy and glioblastoma multiforme, as well as developing treatments for gastric cancer, pancreatic cancer, non-small cell lung cancer, and other cancers. Registered in the Cayman Islands.